CCL3 and neoplasm: Fig 3 provides examples of two modulated cytokines for either the tumor (GM-CSF, Fig 3B) or the host (MIP-1a, Fig 3C), which are increased specifically upon treatment with RG7356, as effector-function competent IgG1, and not by the IgG4.